Effects of HSV-1 and ZIKV on Lipid Metabolism in Neuronal Cells
Both HSV-1 and ZIKV were found to downregulate key lipid metabolism pathways in iPSC-derived neuronal cells, affecting various lipid types like sphingolipids and glycerophospholipids.
- Tags
- #MSResearch
- Most relevant to
- —
Why it matters
These findings suggest that alterations in lipid metabolism might play a role in the development of neurological diseases, which could be relevant for understanding conditions like multiple sclerosis.
What this does not prove
The study only includes in vitro results and does not directly link these metabolic changes to MS pathology in humans, nor does it confirm that viral models adequately reflect human disease progression.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-08-10
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
Original sources
- Primary evidenceReprogramming lipid metabolism in virus-infected neuronal cells. ↗DOI: 10.21203/rs.3.rs-10472222/v1
Supporting passages (3)
publication date2026-08-10
findingsWe found that both HSV-1 and ZIKV downregulate lipid metabolism, sphingolipid metabolism, glycerophospholipid, and plasmalogen pathways in iPSC-derived neuronal cells, which may contribute to the pathogenesis of neurological diseases.
limitationsTitle: Reprogramming lipid metabolism in virus-infected neuronal cells.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.